Early initiation of low-dose aspirin for reduction in preeclampsia risk in high-risk women: A secondary analysis of the MFMU High-Risk Aspirin Study

Journal of Perinatology

Volumn 35, Issue 5, 2015, Pages 328-331

  Moore, G S ^a   Allshouse, A A ^b   Post, A L ^a   Galan, H L ^a   Heyborne, K D ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Food Science and Human Nutrition   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; PLACEBO;

ADULT; ARTICLE; DOSE RESPONSE; EARLY INTERVENTION; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PREECLAMPSIA; PREGNANCY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SMALL FOR DATE INFANT; BIRTH WEIGHT; CLINICAL TRIAL; CONTROLLED STUDY; GESTATIONAL AGE; MULTICENTER STUDY; NEWBORN; PRE-ECLAMPSIA; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADULT; ASPIRIN; BIRTH WEIGHT; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; RISK FACTORS;

EID: 84929134296     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2014.214     Document Type: Article

References (25)

1. Dolea C, AbouZahr C. Global burden of hypertensive disorders of pregnancy in the year 2000. Evidence and Information for Policy (EIP). World Health Organization: Geneva, 2003
2. Wallis AB, Saftlas AF, Hsia J, Atrash HK. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. Am J Hypertens 2008; 21(5): 521-526
3. Walsh SW, Behr MJ, Allen NH. Placental prostacyclin production in normal and toxemic pregnancies. Am J Obstet Gynecol 1985; 151(1): 110-115
4. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365(9461): 785-799
5. Ylikorkala O, Makila UM. Prostacyclin and thromboxane in gynecology and obstetrics. Am J Obstet Gynecol 1985; 152(3): 318-329
6. Borzychowski AM, Sargent IL, Redman CW. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med 2006; 11(5): 309-316
7. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S., et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010; 116(2 Pt 1): 402-414
8. Tohgi H, Konno S, Tamura K, Kimura B, Kawano K. Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin. Stroke 1992; 23(10): 1400-1403
9. Walsh SW. Low-dose aspirin: treatment for the imbalance of increased thromboxane and decreased prostacyclin in preeclampsia. Am J Perinatol 1989; 6(2): 124-132
10. Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E., et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. New Engl J Med 1998; 338(11): 701-705
11. Villa PM, Kajantie E, Raikkonen K, Pesonen AK, Hamalainen E, Vainio M., et al. Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials. BJOG 2013; 120(1): 64-74
12. Brenner WE, Edelman DA, Hendricks CH. A standard of fetal growth for the United States of America. Am J Obstet Gynecol 1976; 126(5): 555-564
13. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA, Group PC. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007; 369(9575): 1791-1798
14. CLASP Collaborative Group. Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancy. BJOG 1995; 102(11): 861-868
15. Mayhew TM. Fetoplacental angiogenesis during gestation is biphasic, longitudinal and occurs by proliferation and remodelling of vascular endothelial cells. Placenta 2002; 23(10): 742-750
16. Bdolah Y, Lam C, Rajakumar A, Shivalingappa V, Mutter W, Sachs BP., et al. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?. Am J Obstet Gynecol 2008; 198(4): 428 e421-426
17. Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol 2013; 209(6): 544 e541-544 e512
18. Stergiotou I, Crispi F, Valenzuela-Alcaraz B, Bijnens B, Gratacos E. Patterns of maternal vascular remodeling and responsiveness in early- versus late-onset preeclampsia. Am J Obstet Gynecol 2013; 209(6): 558 e551-558 e514
19. Nelson DB, Ziadie MS, McIntire DD, Rogers BB, Leveno KJ. Placental pathology suggesting that preeclampsia is more than one disease. Am J Obstet Gynecol 2014; 210(1): 66 e61-e67
20. Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M., et al. Firsttrimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol 2013; 208(1): 58 e51-57
21. Roberge S, Villa P, Nicolaides K, Giguere Y, Vainio M, Bakthi A., et al. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther 2012; 31(3): 141-146
22. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994; 343(8898): 619-629
23. Wallenburg HC, Rotmans N. Enhanced reactivity of the platelet thromboxane pathway in normotensive and hypertensive pregnancies with insufficient fetal growth. Am J Obstet Gynecol 1982; 144(5): 523-528
24. Schiff E, Peleg E, Goldenberg M, Rosenthal T, Ruppin E, Tamarkin M., et al. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. New Engl J Med 1989; 321(6): 351-356
25. American College of O, Gynecologists, Task Force on Hypertension in P. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122(5): 1122-1131